Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: A systematic review and meta-analysis of randomized controlled trials

Taro Kishi, Yuki Matsuda, Nakao Iwata

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: A systematic review and meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Keyphrases